You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美股異動 | 輝瑞(PFE.US)漲2% 以5.25億美元收購ReViral以增強其RSV抗病毒產品組合
格隆匯 04-07 22:57
格隆匯4月7日丨輝瑞(PFE.US)漲2.37%,報54.13美元,總市值3044億美元。根據Truist分析師Robyn Karnoskas的一份報吿,輝瑞計劃以5.25億美元收購少數人持股的ReViral,這可能標誌着生物製藥公司之間達成更多交易,特別是在小公司面臨上市挑戰的情況下。ReViral的主要實驗藥物西那託韋正處於對抗呼吸道合胞病毒的第二階段測試。正在開發RSV疫苗的輝瑞公司表示,西那託韋可能會產生15億美元的銷售額。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account